
FDA approves dexmedetomidine sublingual film for at-home use in adults with schizophrenia, schizoaffective disorder, or bipolar I or II disorder.
Supplements and Featured Publications
In this AJMC® Profiles in Care, key stakeholders affiliated with various institutions emphasizing obesity care share best practices and effective approaches for development of a care pathway for treating patients with obesity.






